PRKAA1 and hepatocellular carcinoma: In this study, we demonstrate for the first time in cell lines and HCC tissue samples that AMPK and AMPK-activating drugs traditionally used to counter the metabolic changes observed in diabetes could be effective in restraining HCC cell proliferation.